Skip to content

AI-Powered Synthetic Biology Milestone: First Programmable Multi-Cellular Living Therapeutic Demonstrates 89% Remission in Autoimmune Trial

AI-Powered Synthetic Biology Milestone: First Programmable Multi-Cellular Living Therapeutic Demonstrates 89% Remission in Autoimmune Trial
Published: